Advanced Enzyme Technologies informs about outcome of board meeting

05 Feb 2022 Evaluate

With reference to the notice of Board Meeting dated January 28, 2022, Advanced Enzyme Technologies has informed that the Board of Directors at its Meeting held on February 05, 2022 (commenced at 10:55 am and concluded at 11:30 am) has, approved the following: Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2021 and Allotment of 9,200 Equity Shares of face value of Rs 2 at an exercise price of Rs 60 per share pursuant to exercise of options under the Employees Stock Option Scheme, 2015 (amended). In view of the above, the following documents are enclosed: Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2021 along with the Limited Review report issued by MSKA & Associates, Statutory Auditors of the Company as an Annexure. The aforesaid un-audited Financial Results along with Limited Review Report are also being uploaded on the website of the Company, www.advancedenzymes.com.

The above information is a part of company’s filings submitted to BSE.

Advanced Enzyme Share Price

358.25 4.10 (1.16%)
03-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.10
Dr. Reddys Lab 1352.75
Cipla 1510.25
Lupin 2367.85
Zydus Lifesciences 975.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.